Point72 Hong Kong Ltd - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 262 filers reported holding NEKTAR THERAPEUTICS in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
Point72 Hong Kong Ltd ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2022$10,000
-89.4%
3,017
-42.5%
0.00%
-100.0%
Q3 2021$94,000
-65.4%
5,248
-66.9%
0.00%
-66.7%
Q2 2021$272,000
+13500.0%
15,849
+11553.7%
0.01%
Q4 2020$2,000
-99.6%
136
-99.4%
0.00%
-100.0%
Q2 2020$489,000
+270.5%
21,131
+192.6%
0.05%
+42.1%
Q3 2019$132,000
+1785.7%
7,222
+3212.8%
0.04%
+1166.7%
Q1 2019$7,000
-30.0%
218
+36.2%
0.00%0.0%
Q3 2018$10,000
-52.4%
160
-18.4%
0.00%
-72.7%
Q1 2018$21,000
+200.0%
196
-51.0%
0.01%
+175.0%
Q3 2016$7,0004000.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q2 2020
NameSharesValueWeighting ↓
Strong Tower Advisory Services 404,972$6,913,0004.02%
GREAT POINT PARTNERS LLC 504,691$9,064,0002.11%
Camber Capital Management LP 3,750,000$67,350,0002.07%
ACT CAPITAL MANAGEMENT, LLC 161,500$2,901,0001.50%
Rhenman & Partners Asset Management AB 950,000$17,062,0001.20%
MAVERICK CAPITAL LTD 5,838,426$104,858,0001.06%
Birchview Capital, LP 72,000$1,293,0000.88%
Bellevue Group AG 4,594,656$82,519,0000.84%
CM Management, LLC 50,000$898,0000.67%
Duquesne Family Office 1,000,000$17,960,0000.58%
View complete list of NEKTAR THERAPEUTICS shareholders